Chinook Therapeutics - Delisted Stock
Chinook Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Chinook Therapeutics was actively traded.
Valuation
Check how we calculate scores
Chinook Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Chinook Therapeutics market risk premium is the additional return an investor will receive from holding Chinook Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Chinook Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Chinook Therapeutics' alpha and beta are two of the key measurements used to evaluate Chinook Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.45 | |||
| Standard Deviation | 7.39 | |||
| Variance | 54.61 | |||
| Downside Variance | 1.98 |
View Chinook Therapeutics Related Equities
| Risk & Return | Correlation |
Chinook Therapeutics Corporate Management
Elected by the shareholders, the Chinook Therapeutics' board of directors comprises two types of representatives: Chinook Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chinook. The board's role is to monitor Chinook Therapeutics' management team and ensure that shareholders' interests are well served. Chinook Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chinook Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tom Frohlich | Chief Officer | Profile | |
| Jodi Jamieson | VP HR | Profile | |
| MS MD | Sr Strategy | Profile | |
| Eric MBA | Chief Officer | Profile | |
| Kirk JD | Sr Counsel | Profile | |
| Alan MD | Ex Officer | Profile | |
| Andrew DVM | Chief Officer | Profile |
Still Interested in Chinook Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Chinook Stock
If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |